These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15868394)

  • 21. New developments in the treatment algorithm for peripheral neuropathic pain.
    de Leon-Casasola O
    Pain Med; 2011 Jul; 12 Suppl 3():S100-8. PubMed ID: 21752181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Algorithm for neuropathic pain treatment: an evidence based proposal.
    Finnerup NB; Otto M; McQuay HJ; Jensen TS; Sindrup SH
    Pain; 2005 Dec; 118(3):289-305. PubMed ID: 16213659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropathic pain--a management update.
    Votrubec M; Thong I
    Aust Fam Physician; 2013 Mar; 42(3):92-7. PubMed ID: 23529516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Guideline of neuropathic pain treatment and dilemma from neurological point of view].
    Yang CM; Chen NC; Shen HC; Chou CH; Yeh PS; Lin HJ; Chang CY; Cheng TJ; Lin KC
    Acta Neurol Taiwan; 2012 Sep; 21(3):136-44. PubMed ID: 23196735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The neuropathic pain: An overview of the current treatment and future therapeutic approaches.
    Cavalli E; Mammana S; Nicoletti F; Bramanti P; Mazzon E
    Int J Immunopathol Pharmacol; 2019; 33():2058738419838383. PubMed ID: 30900486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward a definition of pharmacoresistant neuropathic pain.
    Hansson PT; Attal N; Baron R; Cruccu G
    Eur J Pain; 2009 May; 13(5):439-40. PubMed ID: 19324579
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of neuropathic pain.
    Jensen TS; Finnerup NB
    Curr Opin Support Palliat Care; 2007 Aug; 1(2):126-31. PubMed ID: 18685353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Peripheral neuropathic pain relieved by somatosensory rehabilitation].
    Mathis F; Desfoux N; Sprumont P; Hecker E; Rossier P; Spicher C
    Rev Med Suisse; 2007 Nov; 3(135):2745-8. PubMed ID: 18214230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New data for the pathomechanism of neuropathic pain: therapeutic evidences].
    Tajti J; Szok D; Vécsei L
    Neuropsychopharmacol Hung; 2013 Mar; 15(1):13-7. PubMed ID: 23542755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted pharmacotherapy of evoked phenomena in neuropathic pain: a review of the current evidence.
    Granot R; Day RO; Cohen ML; Murnion B; Garrick R
    Pain Med; 2007; 8(1):48-64. PubMed ID: 17244104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral pharmacotherapeutics for the management of peripheral neuropathic pain conditions - a review of clinical trials.
    Knezevic NN; Jovanovic F; Candido KD; Knezevic I
    Expert Opin Pharmacother; 2020 Dec; 21(18):2231-2248. PubMed ID: 32772737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing Neuropathic Pain in Multiple Sclerosis: Pharmacological Interventions.
    Duffy SS; Lees JG; Perera CJ; Moalem-Taylor G
    Med Chem; 2018 Feb; 14(2):106-119. PubMed ID: 28875858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropathic pain: treatment guidelines and updates.
    Hurley RW; Adams MC; Benzon HT
    Curr Opin Anaesthesiol; 2013 Oct; 26(5):580-7. PubMed ID: 23995060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic neuropathic pain: mechanisms, drug targets and measurement.
    Finnerup NB; Sindrup SH; Jensen TS
    Fundam Clin Pharmacol; 2007 Apr; 21(2):129-36. PubMed ID: 17391285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medicinal Plants for the Treatment of Neuropathic Pain: A Review of Randomized Controlled Trials.
    Ahmadzadeh AM; Pourali G; Mirheidari SB; Shirazinia M; Hamedi M; Mehri A; Amirbeik H; Saghebdoust S; Tayarani-Najaran Z; Sathyapalan T; Forouzanfar F; Sahebkar A
    Curr Pharm Biotechnol; 2024; 25(5):534-562. PubMed ID: 37455451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent trends in neuropathic pain patents.
    Maia RD
    Expert Opin Ther Pat; 2017 May; 27(5):539-546. PubMed ID: 27998196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Management of neuropathic pain].
    Lozeron P; Kubis N
    Rev Med Interne; 2015 Jul; 36(7):480-6. PubMed ID: 25958331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methodological issues associated with clinical trials in neuropathic pain.
    Gilron I
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1399-1402. PubMed ID: 27659719
    [No Abstract]   [Full Text] [Related]  

  • 40. Guidelines for the pharmacological treatment of peripheral neuropathic pain: expert panel recommendations for the middle East region.
    Bohlega S; Alsaadi T; Amir A; Hosny H; Karawagh AM; Moulin D; Riachi N; Salti A; Shelbaya S
    J Int Med Res; 2010; 38(2):295-317. PubMed ID: 20515552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.